journal
MENU ▼
Read by QxMD icon Read
search

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://www.readbyqxmd.com/read/30100692/research-briefs
#1
(no author information available yet)
No abstract text is available yet for this article.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100691/american-society-of-clinical-oncology
#2
Walter Alexander
We review key findings in the areas of prostate cancer, non-small-cell lung cancer, breast cancer, esophageal cancer, pancreatic cancer, leukemias, metastatic colon cancer, and one session on molecular profiling guidance of therapy.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100690/old-and-new-drug-classes-expanding-to-include-glaucoma-treatments
#3
Troy Kish
Poor patient adherence is fueling keen interest in the development of drugs for glaucoma management. Several long-acting formulations of existing medications are in the early stages of development, as are new therapeutic classes such as guanylate cyclase activators.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100689/variation-in-generic-drug-manufacturers-product-characteristics
#4
Karl Matuszewski, Joan Kapusnik-Uner, Michael Man, Robert Pardini, Julie Suko
Objectives: Studies suggest appearance may be an important factor in medication nonadherence. This study was undertaken to characterize the range of appearances and costs of 16 oral solid generic medications in four major chronic diseases/conditions. Methods: We identified frequently prescribed medications in four therapeutic classes-antidiabetics, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), beta blockers, and heart failure drugs-and verified that each had at least three generic manufacturer sources in 2016...
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100688/clarification-of-drug-allergy-information-using-a-standardized-drug-allergy-questionnaire-and-interview
#5
Amy Harig, Amy Rybarczyk, Amanda Benedetti, Jacob Zimmerman
Background: Vague, incomplete, or inaccurate drug-allergy histories can be detrimental to patient safety and affect patient care. There is an increased chance of medication errors if details of a drug allergy are not documented. Incomplete or inaccurate allergy histories may also result in increased time spent by health care providers to clarify an order in question. Published literature from the early 1990s showed that a patient interview can facilitate collection of more complete allergy information and could lead to the removal of a documented drug allergy in approximately one-third of patients...
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100687/real-world-evidence-promise-and-peril-for-medical-product-evaluation
#6
Sanket S Dhruva, Joseph S Ross, Nihar R Desai
Randomized controlled trials have long been the gold standard for evidence in medical product evaluation, but there is growing support for the use of real-world evidence (RWE). The authors review the benefits and limitations of RWE and discuss the implications for P&T committees.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100686/pharmaceutical-approval-update
#7
Mary Choy
Lofexidine hydrocholoride (Lucemyra) for opioid withdrawal; erenumab-aooe (Aimovig) for migraine; and sodium zirconium cyclosilicate (Lokelma) for hyperkalemia.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100685/drug-and-device-news
#8
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100684/fda-guidance-on-503b-provides-leeway-outsourcing-facilities-can-be-co-located-with-503a-pharmacies
#9
Stephen Barlas
FDA guidance on outsourcing facilities and 503A pharmacies.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30100683/ambulatory-pump-safety-managing-home-infusion-patients-admitted-to-the-emergency-department-and-hospital
#10
Matthew Grissinger
Managing home infusion patients in the hospital and emergency department.
August 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013302/american-association-for-cancer-research-and-american-college-of-obstetricians-and-gynecologists
#11
Walter Alexander
We report on sessions on immunotherapies for non-small-cell lung cancer and pancreatic cancer from AACR and on endometriosis, hypoactive sexual desire disorder, neonatal abstinence syndrome, and more from ACOG.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013301/research-briefs
#12
(no author information available yet)
No abstract text is available yet for this article.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013300/satisfaction-with-medication-reconciliation-completed-by-pharmacy-technicians-in-an-emergency-department
#13
Sajani Patel, A Scott Mathis, Jennifer Costello, Hoytin Lee Ghin, Germin Fahim
Purpose: To survey advanced nurse practitioners, physician assistants, nurses, physicians, and resident physicians involved with collecting and reconciling medication histories in the emergency department (ED) to measure their satisfaction with the current process involving pharmacy technicians. Methods: Two sites within a large health system with pharmacy technician-driven medication reconciliation processes asked health care professionals to complete a survey of 20 multiple-choice questions...
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013299/review-of-medication-therapy-for-the-prevention-of-sickle-cell-crisis
#14
Tanya R Riley, Angelo Boss, Dominique McClain, Treavor T Riley
This article reviews the clinical data concerning the uses of hydroxyurea, L-glutamine, and crizanlizumab in treating pain crises associated with sickle cell disease.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013298/metastatic-soft-tissue-sarcomas-a-review-of-treatment-and-new-pharmacotherapies
#15
Eric K Singhi, Donald C Moore, Alaa Muslimani
Soft tissue sarcomas represent a group of heterogeneous mesenchymal tumors that occur rarely in adults. While a variety of histological subtypes exist, some of the most common are leiomyosarcoma and liposarcoma. For eligible patients, standard first-line treatment of metastatic disease has typically comprised anthracycline-containing regimens. While traditional cytotoxic chemotherapy has been the mainstay of treatment in metastatic soft tissue sarcoma, emerging targeted and novel therapies are creating new frontiers of treatment for a variety of histological subtypes...
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013297/medicare-quietly-forces-changes-to-federal-formulary-requirements-changes-nibble-around-the-edge-of-drug-pricing-but-bigger-bites-may-be-coming
#16
Stephen Barlas
Quiet changes in federal health programs make minor but significant consumer-friendly changes in the way drugs are priced for seniors in 2019. The author considers how this lays the groundwork for more radical changes in the future.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013296/etelcalcetide-parsabiv-for-secondary-hyperparathyroidism-in-adults-with-chronic-kidney-disease-on-hemodialysis
#17
Jena Patel, Mary Barna Bridgeman
Etelcalcetide (Parsabiv) for hyperparathyroidism in adults with chronic kidney disease on hemodialysis.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013295/pharmaceutical-approval-update
#18
Mary Choy
Fostamatinib (Tavalisse) for thrombocytopenia in adults with chronic immune thrombocytopenia; coagulation factor Xa (recombinant), inactivated-zhzo (Andexxa) for the reversal of anticoagulation; epoetin alfa-epbx (Retacrit), a biosimilar for the treatment of anemia.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013294/drug-and-device-news
#19
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/30013293/hospitals-search-for-iv-opioids-has-the-dea-been-fast-and-flexible-enough
#20
Stephen Barlas
Hospitals search for IV opioids.
July 2018: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"